Oric Pharmaceuticals, Inc. financial data

Symbol
ORIC on Nasdaq
Industry
Pharmaceutical Preparations
Location
240 E. Grand Ave., 2 Nd Floor, South San Francisco, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.5 K % +0.53%
Debt-to-equity 9.35 % -13.3%
Return On Equity -38.1 % +7.14%
Return On Assets -34.8 % +5.94%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 67.4 M shares +49.5%
Common Stock, Shares, Outstanding 67.4 M shares +49.5%
Entity Public Float 415 M USD +140%
Common Stock, Value, Issued 7 K USD +40%
Weighted Average Number of Shares Outstanding, Basic 67.3 M shares +49.4%
Weighted Average Number of Shares Outstanding, Diluted 67.3 M shares +49.4%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 26.5 M USD +6.68%
Operating Income (Loss) -114 M USD -21.1%
Nonoperating Income (Expense) 12.3 M USD +188%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -102 M USD -13.2%
Earnings Per Share, Basic -1.8 USD/shares +17.8%
Earnings Per Share, Diluted -1.8 USD/shares +17.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 56.4 M USD -4.46%
Assets, Current 324 M USD +67.8%
Property, Plant and Equipment, Net 2.8 M USD -9.99%
Operating Lease, Right-of-Use Asset 9.14 M USD -16.8%
Other Assets, Noncurrent 9.21 M USD -16.8%
Assets 351 M USD +54.8%
Accounts Payable, Current 2.99 M USD +54.8%
Accrued Liabilities, Current 12.2 M USD -5.53%
Liabilities, Current 15.2 M USD +2.31%
Operating Lease, Liability, Noncurrent 7.46 M USD -21%
Other Liabilities, Noncurrent 6.93 M USD -22.7%
Liabilities 22.1 M USD -7.11%
Accumulated Other Comprehensive Income (Loss), Net of Tax -162 K USD +67.5%
Retained Earnings (Accumulated Deficit) -460 M USD -28.4%
Stockholders' Equity Attributable to Parent 329 M USD +62%
Liabilities and Equity 351 M USD +54.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -30.2 M USD -46.3%
Net Cash Provided by (Used in) Financing Activities 125 M USD
Net Cash Provided by (Used in) Investing Activities -61.9 M USD -584%
Common Stock, Shares Authorized 1 B shares 0%
Common Stock, Shares, Issued 67.4 M shares +49.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 33 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 56.9 M USD -4.39%
Deferred Tax Assets, Valuation Allowance 133 M USD +31.1%
Deferred Tax Assets, Gross 136 M USD +29.6%
Operating Lease, Liability 10.2 M USD -15.6%
Depreciation 261 K USD +3.16%
Payments to Acquire Property, Plant, and Equipment 218 K USD -29.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -101 M USD -13.2%
Lessee, Operating Lease, Liability, to be Paid 12 M USD -18.7%
Property, Plant and Equipment, Gross 9.47 M USD +3.4%
Operating Lease, Liability, Current 2.78 M USD +3.51%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.68 M USD -6.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.85 M USD +3.48%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.81 M USD -32.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.68 M USD +0.04%
Deferred Tax Assets, Operating Loss Carryforwards 75.8 M USD +18.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200 M shares 0%
Unrecognized Tax Benefits 2.81 M USD +29.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.77 M USD +3.51%
Operating Lease, Payments 2.76 M USD +25.6%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 2.68 M USD -15.8%
Share-based Payment Arrangement, Expense 16.6 M USD +17.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%